Groen HJ - Search Results

1

Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarction.

van Setten J, Isgum I, Smolonska J, Ripke S, de Jong PA, Oudkerk M, de Koning H, Lammers JW, Zanen P, Groen HJ, Boezen HM, Postma DS, Wijmenga C, Viergever MA, Mali WP, de Bakker PI. van Setten J, et al. Among authors: groen hj. Atherosclerosis. 2013 Jun;228(2):400-5. doi: 10.1016/j.atherosclerosis.2013.02.039. Epub 2013 Mar 13. Atherosclerosis. 2013. PMID: 23561647 Free article.

2

Pulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic, and nailfold capillary patterns.

Groen H, ter Borg EJ, Postma DS, Wouda AA, van der Mark TW, Kallenberg CG. Groen H, et al. Am J Med. 1992 Dec;93(6):619-27. doi: 10.1016/0002-9343(92)90194-g. Am J Med. 1992. PMID: 1466357

3

Pulmonary function in patients presenting with Raynaud's phenomenon without an underlying connective tissue disease. A prospective, longitudinal study.

Aalbers R, Groen H, Postma DS, Van der Mark TW, Wouda AA, Reig RP, Kallenberg CG. Aalbers R, et al. J Rheumatol. 1989 Jan;16(1):36-41. J Rheumatol. 1989. PMID: 2785598

4

Clinical evaluation of lymphocyte sub-populations and oxygen radical production in sarcoidosis and idiopathic pulmonary fibrosis.

Groen H, Hamstra M, Aalbers R, van der Mark TW, Koëter GH, Postma DS. Groen H, et al. Respir Med. 1994 Jan;88(1):55-64. doi: 10.1016/0954-6111(94)90175-9. Respir Med. 1994. PMID: 8029515 Free article.

5

Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide.

Groen H, Bootsma H, Postma DS, Kallenberg CG. Groen H, et al. J Rheumatol. 1993 Jun;20(6):1055-7. J Rheumatol. 1993. PMID: 8350313

6

Interstitial lung disease and myositis in a patient with simultaneously occurring sarcoidosis and scleroderma.

Groen H, Postma DS, Kallenberg CG. Groen H, et al. Chest. 1993 Oct;104(4):1298-300. doi: 10.1378/chest.104.4.1298. Chest. 1993. PMID: 8404219

7

Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors.

Spierings DC, de Vries EG, Timens W, Groen HJ, Boezen HM, de Jong S. Spierings DC, et al. Among authors: groen hj. Clin Cancer Res. 2003 Aug 15;9(9):3397-405. Clin Cancer Res. 2003. PMID: 12960128

8

Phase II study of docetaxel and carboplatin as second-line treatment in NSCLC.

Wachters FM, van Putten JW, Boezen HM, Groen HJ. Wachters FM, et al. Among authors: groen hj. Lung Cancer. 2004 Aug;45(2):255-62. doi: 10.1016/j.lungcan.2004.02.006. Lung Cancer. 2004. PMID: 15246198 Free article. Clinical Trial.

9

Nodule management protocol of the NELSON randomised lung cancer screening trial.

Xu DM, Gietema H, de Koning H, Vernhout R, Nackaerts K, Prokop M, Weenink C, Lammers JW, Groen H, Oudkerk M, van Klaveren R. Xu DM, et al. Lung Cancer. 2006 Nov;54(2):177-84. doi: 10.1016/j.lungcan.2006.08.006. Epub 2006 Sep 20. Lung Cancer. 2006. PMID: 16989922 Clinical Trial.

10

Microarray amplification bias: loss of 30% differentially expressed genes due to long probe - poly(A)-tail distances.

Boelens MC, te Meerman GJ, Gibcus JH, Blokzijl T, Boezen HM, Timens W, Postma DS, Groen HJ, van den Berg A. Boelens MC, et al. Among authors: groen hj. BMC Genomics. 2007 Aug 15;8:277. doi: 10.1186/1471-2164-8-277. BMC Genomics. 2007. PMID: 17697374 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

459 results

Search Page

Filters